A detailed history of Legato Capital Management LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 115,463 shares of DCTH stock, worth $1.39 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
115,463
Previous 115,463 -0.0%
Holding current value
$1.39 Million
Previous $966,000 7.87%
% of portfolio
0.14%
Previous 0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$4.47 - $8.37 $516,119 - $966,425
115,463 New
115,463 $966,000

Others Institutions Holding DCTH

About DELCATH SYSTEMS, INC.


  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $103M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.